WhatsApp
Facebook
Instagram
X (Twitter)
YouTube
LinkedIn

24/7 Customer Support

xolair omalizumab for Injection urticaria and asthma 150mg

Description

 Indication & Scope

Xolair® Omalizumab for Injection treats moderate to severe uncontrolled allergic asthma; treatment of chronic spontaneous urticaria resistant to antihistamines.

  • Mechanism: Monoclonal antibody that specifically binds free IgE, reduces IgE concentration in blood, inhibits mast cell and basophil degranulation to block allergic cascade reactions.
  • Drug class: Anti-IgE monoclonal antibody, biological anti-allergic agent.
  • Clinical use: Long-term add-on therapy for refractory allergic asthma; second-line treatment for chronic spontaneous urticaria.
Specification
Generic Name Omalizumab for Injection
Brand Name Xolair
Ingredient Omalizumab
Dosage Form Injection
Package [Omalizumab 150mg*1 vial + injection water 2ml*1 vial]/box;

[Omalizumab 150mg*4 vial + injection water 2ml*4 vial]/box;

[Omalizumab 150mg*10 vial + injection water 2ml*10 vial]/box

Conditions Treated IgE-mediated moderate-severe allergic asthma, antihistamine-resistant chronic spontaneous urticaria
Taboos Severe hypersensitivity to omalizumab or excipients; acute severe asthma attack requiring emergency rescue
Place of origin Schaffhauserstrasse, 4332 Stein, Switzerland
Prescription type Prescription-only
Storage Conditions Store refrigerated at 2°C – 8°C, do not freeze; protect from light during transportation and storage
Manufacturer Novartis Pharma Stein AG
Registration Authority National Medical Products Administration (NMPA), China
Approval number SJ20170042
Approval Date Jan 27, 2022
Shelf Life 24 months

How to use ?

Recommended Dose: Dose is calculated strictly based on body weight and baseline total IgE level, administered subcutaneously every 2 or 4 weeks.

 

Time: Fixed subcutaneous injection every 2 or 4 weeks at the same interval.

 

Instructions for use: Reconstitute lyophilized powder strictly per specification before injection; administer subcutaneously in upper arm, thigh or abdomen; monitor for hypersensitivity for at least 2 hours after injection.

 

Interaction: No direct drug-drug interactions reported; dosage adjustment is not needed with inhaled steroids, antihistamines or bronchodilators.

 

Side effects:

1. Common: injection site redness, swelling, fatigue, headache, joint pain.

2. Rare: anaphylaxis, parasitic infection risk, mild fever.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References
2.NMPA
3.FDA
4.EMA

FAQ

What two main allergic diseases are covered by the indications of Omalizumab for Injection?

Moderate-severe uncontrolled allergic asthma and chronic spontaneous urticaria unresponsive to antihistamines.

What factor determines the specific dosage and injection interval of Omalizumab for Injection?

Dosage and interval depend on body weight and pretreatment total serum IgE concentration.

What mandatory monitoring is required right after each injection of Omalizumab for Injection?

Continuous observation for allergic reactions for no less than two hours after subcutaneous injection.

Can Omalizumab for Injection be used to relieve sudden severe asthma attacks?

No, it is forbidden for emergency rescue of acute severe asthma exacerbations.

Xolair® | Omalizumab for Injection | Allergic Asthma/Urticaria | DengYueRX

INN: Omalizumab for Injection
Indications: Allergic asthma and urticaria
Dosage Form: Injection
Strength: 150mg/vial

Original price was: $302.02.Current price is: $256.71.

Low MOQ

WHO-GMP

Worldwide Delivery

Compliance and Regulatory Documents

Related Products

Scroll to Top

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00